The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

被引:365
作者
Ainiala, H
Loukkola, J
Peltola, J
Korpela, M
Hietaharju, A
机构
[1] Tampere Univ Hosp, Dept Neurol & Rehabil, FIN-33521 Tampere, Finland
[2] Tampere Univ Hosp, Div Rheumatol, Dept Internal Med, Tampere, Finland
关键词
D O I
10.1212/WNL.57.3.496
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe the prevalence of neuropsychiatric (NP) syndromes in a Finnish population of patients with systemic lupus erythematosus (SLE) and to classify them according to the recently developed American College of Rheumatology (ACR) nomenclature and case definitions for NPSLE. Methods: Cross-sectional, population-based study covering an area with 440,000 people. A total of 58 patients with a definite diagnosis of SLE and aged 16 to 65 years were found in the computerized database of the area hospitals. Of these, 46 (79%) agreed to participate. The diagnosis of various NP syndromes was based on clinical impression (H.A.) following history, examination, review of medical records, and neuropsychologic testing. Results: At least one NP syndrome was identified in 42 patients (91%). The most frequent manifestation was cognitive dysfunction (n = 37; 81%), followed by headache (n = 25; 54%) and mood disorder (n = 20; 43%). When mild NP syndromes (mild cognitive deficit, headache, mild depression, anxiety, electroneuromyography-negative polyneuropathy) were excluded, the prevalence of NPSLE dropped to 46%. Conclusions: According to the ACR nomenclature, there is a high prevalence of NP manifestations in a population-based sample of patients with SLE. Most NP syndromes were classified as minor; if they were excluded, the 46%, prevalence of NPSLE would be slightly less than estimated in previous studies.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 38 条
[1]  
Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151
[2]  
BECK AT, 1974, PSYCHOL REP, V34, P1184
[3]   PREVALENCE OF COGNITIVE IMPAIRMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CARBOTTE, RM ;
DENBURG, SD ;
DENBURG, JA .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1986, 174 (06) :357-364
[4]   Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature [J].
Cuadrado, MJ ;
Khamashta, MA ;
Ballesteros, A ;
Godfrey, T ;
Simon, MJ ;
Hughes, GRV .
MEDICINE, 2000, 79 (01) :57-68
[5]  
DELIS DC, 1987, CALIFORNIA VERBAL LE
[6]   NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS [J].
ESTES, D ;
CHRISTIAN, CL .
MEDICINE, 1971, 50 (02) :85-+
[7]   NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS - DIAGNOSIS, CLINICAL SPECTRUM, AND RELATIONSHIP TO OTHER FEATURES OF DISEASE [J].
FEINGLASS, EJ ;
ARNETT, FC ;
DORSCH, CA ;
ZIZIC, TM ;
STEVENS, MB .
MEDICINE, 1976, 55 (04) :323-339
[8]   FREQUENCY, ETIOLOGY, AND PREVENTION OF STROKE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FUTRELL, N ;
MILLIKAN, C .
STROKE, 1989, 20 (05) :583-591
[9]   CENTRAL-NERVOUS-SYSTEM DISEASE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FUTRELL, N ;
SCHULTZ, LR ;
MILLIKAN, C .
NEUROLOGY, 1992, 42 (09) :1649-1657
[10]   NERVOUS-SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
GIBSON, T ;
MYERS, AR .
ANNALS OF THE RHEUMATIC DISEASES, 1976, 35 (05) :398-406